Mortality News and Research

RSS

New consensus on managing AMI patients during COVID-19 released

The Society for Cardiovascular Angiography and Interventions, along with the American College of Cardiology and American College of Emergency Physicians have released a consensus statement that provides recommendations for a systematic approach for the care of patients with an acute myocardial infarction during the coronavirus disease-2019 pandemic.

21 Apr 2020

Role of ACE/ARB inhibitors in the treatment of COVID-19

A new opinion piece published in the journal Circulation Research in April 2020 defends the use of antihypertensive drugs called ACE inhibitors and ARBs in patients with pandemic viral pneumonia called COVID-19.

20 Apr 2020

Mutations in novel coronavirus make it more dangerous

A new report published on the preprint server medRxiv in April 2020 reveals that the novel coronavirus SARS-CoV-2 shows the presence of new mutations acquired within infected human cases, which significantly increase its ability to cause human disease.

20 Apr 2020

Do ACE inhibitors increase SARS-CoV-2 binding to ACE2?

The COVID-19 pandemic has forced clinicians and academicians to intensive research to find evidence for many conventional therapies. A new round-up editorial published in the journal Cardiovascular Research in April 2020 summarizes the current clinical grounds for and against the use of the commonly used angiotensin axis inhibitors in patients with COVID-19.

20 Apr 2020

HIV-1 and influenza antivirals not effective for treating mild-to-moderate COVID-19 cases

An exploratory randomized, controlled study on the safety and efficacy of either lopinavir/ritonavir (LPV/r) or Arbidol--antivirals that are used in some countries against HIV-1 and to treat influenza , respectively--as treatments for COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, suggests that neither drug improves the clinical outcome of patients hospitalized with mild-to-moderate cases of the disease over supportive care.

20 Apr 2020

Hypertensive pregnancy disorders may lead to mental health conditions in children

Hypertensive pregnancy disorders, especially preeclampsia, a form of high blood pressure during pregnancy, may lead to adverse mental health conditions in children, according to new research published today in Hypertension, an American Heart Association journal.

20 Apr 2020

Prostate cancer mortality rates predicted to fall in the EU but rise in Poland

Death rates from prostate cancer are predicted to fall in 2020 in the EU, largely due to better diagnosis and treatment, according to new research published in the leading cancer journal Annals of Oncology today (Monday).

20 Apr 2020

Restrictive healthcare policies may delay diagnosis and treatment of tuberculosis

The introduction of policies that restrict healthcare access for visitors and migrants not entitled to free NHS care may be associated with delays in diagnosis and treatment for patients with tuberculosis (TB) who were not born in the UK, according to a study published in the open access journal BMC Public Health.

20 Apr 2020

Hypertensive pregnancy disorders may lead to mental health conditions in children

Hypertensive pregnancy disorders, especially preeclampsia, may lead to adverse mental health conditions in children.

20 Apr 2020

Remdesivir prevents COVID-19 progression to severe pneumonia, animal study shows

A team of scientists at the National Institute of Allergy and Infectious Diseases, which is part of the U.S. National Institutes of Health, has tested the efficacy of remdesivir, a nucleotide analog prodrug with a broad antiviral activity, as a COVID-19 treatment.

20 Apr 2020

Smoking doubles risk of severe COVID-19 disease

The fatality rate among infected people increases among the elderly and those with underlying medical conditions. Now, a new study published as a pre-print on medXriv, links smoking to the progression of COVID-19 disease, suggesting that the odds of disease progression is more than double in smokers.

20 Apr 2020

Poorer regions in the Philippines have more COVID-19 cases

The coronavirus disease (COVID-19) has dramatically affected European countries and the United States, reporting the highest number of confirmed cases. In Asia, though the number of infections gradually increases, some countries have reported high death rates, including Indonesia and the Philippines.

20 Apr 2020

How are the interventions against COVID-19 working in Sweden?

In a new study, Swedish researchers speculate the effects of the present intervention strategies on the healthcare system as the COVID-19 pandemic affects the nation. Their study titled, “Intervention strategies against COVID-19 and their estimated impact on Swedish healthcare capacity,” has not been published yet; however, the findings are available as pre-peer-reviewed study at medRxiv.

19 Apr 2020

Study shows huge effect of obesity on pancreatic cancer development

Pancreatic cancer is expected to become the second-deadliest cancer in the United States by 2030, driven in part by rising obesity rates.

17 Apr 2020

Patient-level Key Performance Indicator set developed for Fracture Liaison Services

The International Osteoporosis Foundation (IOF) Capture the Fracture® Working Group in collaboration with the Fragility Fracture Network Secondary Fragility Fracture Special Interest Group and National Osteoporosis Foundation has adapted existing metrics from the UK-based Fracture Liaison Service Database Audit to develop a patient-level Key Performance Indicator (KPI) set for Fracture Liaison Services (FLSs).

17 Apr 2020

Death rates from prostate cancer predicted to decline overall in EU

Death rates from prostate cancer are predicted to fall in 2020 in the EU, largely due to better diagnosis and treatment.

17 Apr 2020

Elderly patients underestimate the danger of pneumonia

Elderly patients who are hospitalised with pneumonia are twice as likely to die as those hospitalised with hip fractures.

17 Apr 2020

Gimsilumab trial starts in first US patient with ARDS and COVID-19

The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.

16 Apr 2020

Octapharma USA supports new COVID-19 clinical trial

Octapharma USA is supporting a new investigator initiated clinical trial led by George Sakoulas, M.D. of Sharp Memorial Hospital in San Diego, California focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing respiratory failure who become ventilator dependent.

16 Apr 2020

Pre-frailty occurs in 45% of 40-49 year old people, study finds

With all eyes on avoiding major illness this year, health researchers are urging people as young as 40 to build physical and mental health to reduce or even avoid 'frailty' and higher mortality risk.

16 Apr 2020